タモキシフェンの乳がん再発予防効果に及ぼすCYP2D6およびABCC2遺伝子多型の影響

25th JSSX Annual meeting

Session ID : 2-D-10-3

Conference information

Host: The Japanese Society for the Study of Xenobiotics

Oral Presentations 14. P450 - 2

EFFECTS OF POLYMORPHISMS IN CYP2D6 AND ABCC2 ON CLINICAL OUTCOMES OF ADJUVANT TAMOXIFEN THERAPY FOR BREAST CANCER PATIENTS

Author information

*Kazuma Kiyotani
Laboratory for Phamacogenetics, RIKEN Center for Genomic Medicine
Taisei Mushiroda
Laboratory for Phamacogenetics, RIKEN Center for Genomic Medicine
Chiyo K Imamura
Department of Clinical Pharmacokinetics and Pharmacodynamics, School of Medicine, Keio University
Naoya Hosono
Laboratory for Genotyping Development, RIKEN Center for Genomic Medicine
Tatsuhiko Tsunoda
Laboratory for Medical Informatics, RIKEN Center for Genomic Medicine
Michiaki Kubo
Laboratory for Genotyping Development, RIKEN Center for Genomic Medicine
Yusuke Tanigawara
Department of Clinical Pharmacokinetics and Pharmacodynamics, School of Medicine, Keio University
Fuminori Aki
Itoh Surgery and Breast Clinic
Koichi Hirata
1st Department of Surgery, Sapporo Medical University
Yuichi Takatsuka
Department of Breast Surgery, Kansai Rosai Hospital
Minoru Okazaki
Sapporo Breast Surgical Clinic
Shozo Ohsumi
Department of Breast Oncology, Shikoku Cancer Center
Takashi Yamakawa
Yamakawa Breast Clinic
Mitsunori Sasa
Tokushima Breast Care Clinic
Yusuke Nakamura
Laboratory for Phamacogenetics, RIKEN Center for Genomic Medicine
Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, The University of Tokyo
Hitoshi Zembutsu
Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, The University of Tokyo

CONFERENCE PROCEEDINGS FREE ACCESS

Details